Simplify, Personalize, Suppress: Novel Oral ART for HIV Management
May 22, 2026Given persistent unmet needs in the management of virologically suppressed HIV, this program aims to strengthen clinicians’ knowledge of resistance, safety, adherence, and drug–drug interactions of current regimens and guidance on integrating novel oral regimens in development into individualized, guideline-based care. In this activity, an expert in infectious diseases discusses novel oral antiretroviral therapy (ART) for the management of human immunodeficiency virus (HIV).
